+

WO2008015530A3 - Stable solid oral formulation of pantoprazole - Google Patents

Stable solid oral formulation of pantoprazole Download PDF

Info

Publication number
WO2008015530A3
WO2008015530A3 PCT/IB2007/002176 IB2007002176W WO2008015530A3 WO 2008015530 A3 WO2008015530 A3 WO 2008015530A3 IB 2007002176 W IB2007002176 W IB 2007002176W WO 2008015530 A3 WO2008015530 A3 WO 2008015530A3
Authority
WO
WIPO (PCT)
Prior art keywords
pantoprazole
solid oral
oral formulation
stable solid
relates
Prior art date
Application number
PCT/IB2007/002176
Other languages
French (fr)
Other versions
WO2008015530A2 (en
Inventor
Haranatha Babu Balanagu
Shailesh Suresh Bhamare
Kishor Dattatray Deo
Sumanth Reddy Vatti
Sivakumaran Meenakshisunderam
Original Assignee
Aurobindo Pharma Ltd
Haranatha Babu Balanagu
Shailesh Suresh Bhamare
Kishor Dattatray Deo
Sumanth Reddy Vatti
Sivakumaran Meenakshisunderam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aurobindo Pharma Ltd, Haranatha Babu Balanagu, Shailesh Suresh Bhamare, Kishor Dattatray Deo, Sumanth Reddy Vatti, Sivakumaran Meenakshisunderam filed Critical Aurobindo Pharma Ltd
Publication of WO2008015530A2 publication Critical patent/WO2008015530A2/en
Publication of WO2008015530A3 publication Critical patent/WO2008015530A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a stable formulation comprising an acid-labile benzimidazole compound. More particularly, the present invention relates to a stable formulation comprising pantoprazole or its pharmaceutically acceptable salts. The present invention also relates to a process for the preparation of a stable formulation containing pantoprazole or its pharmaceutically acceptable salts.
PCT/IB2007/002176 2006-08-03 2007-07-30 Stable solid oral formulation of pantoprazole WO2008015530A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1380/CHE/2006 2006-08-03
IN1380CH2006 2006-08-03

Publications (2)

Publication Number Publication Date
WO2008015530A2 WO2008015530A2 (en) 2008-02-07
WO2008015530A3 true WO2008015530A3 (en) 2009-02-26

Family

ID=38720303

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/002176 WO2008015530A2 (en) 2006-08-03 2007-07-30 Stable solid oral formulation of pantoprazole

Country Status (1)

Country Link
WO (1) WO2008015530A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102406656A (en) * 2011-11-21 2012-04-11 南开大学 Sodium bicarbonate enteric-coated tablet and preparation method thereof
CN105380919A (en) * 2015-11-20 2016-03-09 世贸天阶制药（江苏）有限责任公司 Pantoprazole sodium enteric-coated tablet and preparation method thereof
GB201804621D0 (en) * 2018-03-22 2018-05-09 Bcm Specials Ltd Formulation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997002020A1 (en) * 1995-07-05 1997-01-23 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole
US20040146558A1 (en) * 2003-01-28 2004-07-29 Kyowa Pharmaceutical Co., Ltd. Oral enteric-coated preparation
CA2557791A1 (en) * 2004-03-26 2005-10-06 Eisai R&D Management Co., Ltd. Controlled-release pharmaceutical composition and method for producing the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997002020A1 (en) * 1995-07-05 1997-01-23 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole
US20040146558A1 (en) * 2003-01-28 2004-07-29 Kyowa Pharmaceutical Co., Ltd. Oral enteric-coated preparation
CA2557791A1 (en) * 2004-03-26 2005-10-06 Eisai R&D Management Co., Ltd. Controlled-release pharmaceutical composition and method for producing the same

Also Published As

Publication number Publication date
WO2008015530A2 (en) 2008-02-07

Similar Documents

Publication Publication Date Title
WO2007087548A3 (en) Chemical compounds
WO2009066326A3 (en) Improved process for the preparation of prasugrel and its pharmaceutically acceptable salts
WO2009115178A3 (en) Gingival wafer
WO2007135527A3 (en) Benzimidazolyl compounds
WO2008096001A8 (en) Hcv inhibiting macrocyclic phenylcarbamates
MX2010010647A (en) Process for preparing orally administered dabigatran formulations.
WO2006011159A3 (en) Stabilized pharmaceutical composition containing rabeprazole sodium with improved bioavailability
WO2009032034A3 (en) Stabilized picoplatin dosage form
WO2009147170A3 (en) Drug combinations comprising a dgat inhibitor and a ppar-agonist
NO20083708L (en) 4-Phenyl-thiazole-5-carboxylic acid and 4-phenyl-thiazole-5-carboxylmides as PLK1 inhibitors
WO2008136392A1 (en) Preparation for oral administration
WO2008006795A3 (en) Indole compounds
WO2009105969A8 (en) Epothilone analogues, their pharmaceutical compositions, their use and their preparations
WO2009013545A3 (en) Chemical compounds
WO2010049449A3 (en) Novel salts of sunitinib
NO20080033L (en) Quinoline derivatives as NK3 antagonists
WO2009060952A1 (en) Novel preparation
WO2006134021A3 (en) Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof
WO2009126861A3 (en) Triazolopyridine compounds useful as dgat1 inhibitors
WO2007112913A3 (en) Benzimidazole derivatives
IN2012DN04868A (en)
WO2008081268A3 (en) Pharmaceutical compositions of entacapone
WO2007007182A3 (en) Solid and liquid dosage forms of an antiepileptic agent
WO2007110765A3 (en) Processes for the preparation of octreotide
WO2008015530A3 (en) Stable solid oral formulation of pantoprazole

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07804668

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07804668

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载